Benign prostatic hyperplasia (BPH) is a common condition among middle-aged and older men. The stromal and, to a lesser degree, epithelial cells of the prostatic transition zone become hyperplastic, causing the prostate to enlarge. While this zone grows throughout life, the prevalence of BPH increases with age, rising from about 8% in the third decade of life to greater than 90% in the ninth decade.[1] The etiology is multifactorial and not well understood. Family history, age, and hormone concentrations appear to play a role in BPH development. Obesity has also been linked to increased risk of BPH and lower urinary tract symptoms.[2] Testosterone and dihydrotestosterone, while necessary for BPH to occur, are not the sole causes of the condition. The role of estrogen in BPH remains unclear. Other contributing factors include inflammation and diet.[3] Symptoms are related to obstruction of the urethra and include hesitancy, reduced urine flow rate, dribbling, urgency, frequency, and nocturia.
The following factors are associated with increased risk of BPH:
Aging. BPH occurs more commonly with advancing age.
Family history. Data suggest an autosomal dominant genetic pattern.[4]
Androgen. Higher dihydrotestosterone concentrations are associated with BPH.
Obesity. Excessive adiposity may make detection more difficult via digital rectal examination. Obesity, particularly abdominal obesity, may also increase risk for BPH likely as a result of hyperinsulinemia.[5][6] Elevated levels of estrogens secondary to conversion from testosterone in adipose tissues may also play a role.
Physical inactivity. The Health Professionals Study and Massachusetts Male Aging Study found lower levels of physical activity to be associated with increased risk for BPH.[7][8]
Diet. Red meat and elevated fat intake have been shown to increase risk for BPH, while increased vegetable consumption has been shown to decrease risk.[9]
Beverage choices. Greater coffee or total caffeine intake increases the odds of BPH progression.[10]
Metabolic syndrome and diabetes. Men with metabolic syndrome have a higher prostate growth rate and larger prostate volumes than men without metabolic syndrome.[11] Similarly, poor glycemic control has been linked to prostate enlargement.[12]
Diagnosis begins with a good history, noting relevant signs and symptoms, as well as medications and any medical conditions that may contribute to urinary dysfunction. It can be helpful to administer a scoring test to gauge symptom severity; some examples are American Urologic Association Symptom Score Index and International Prostate Symptom Score. Urinalysis should always be performed to check for blood, crystals, or infection. Digital examination will typically detect prostate enlargement. The surface of the prostate should be smooth and is usually symmetrical; asymmetry or induration suggests malignancy. Some men with large prostates have no obstructive symptoms, while men with small prostates may have obstructive symptoms.
Prostate biopsy, ultrasound, and/or the prostate-specific antigen (PSA) blood test help rule out malignancy and confirm a diagnosis of BPH. Other tests are available to evaluate bladder and urethral function, such as urine flow rate and post-void residual volume. Urination frequency and volume measurements can be helpful, especially if symptoms occur primarily at night. By keeping track of fluid intake and urine output, it is possible to determine if excessive fluid intake may be contributing to urinary frequency and nocturia.
The purpose of BPH treatment is to improve the patient’s quality of life. Restriction of fluids for 1-2 hours prior to bedtime may help improve nocturnal frequency. Sitting while urinating can increase bladder emptying for men with BPH.[13]
Observation alone (“watchful waiting”) is appropriate if symptoms are mild or not bothersome.
Medical treatment includes use of alpha-1-adrenergic antagonists, such as prazosin, terazosin, doxazosin, tamsulosin, and alfuzosin, which relax smooth muscle and allow for increased urinary flow rate. These medications are the most common first-line pharmaceutical treatment for BPH. The various drugs in this class appear to have similar efficacy. Choice of drug may be based on side effect profile as well as cost.[14] The most common side effect is orthostatic hypotension, the occurrence of which can be reduced by taking the medication just prior to bedtime.[15]
In cases of moderate or greater prostate enlargement, 5-alpha-reductase inhibitors, such as finasteride and dutasteride, can be administered to block the conversion of testosterone to dihydrotestosterone. The 5-alpha reductase inhibitors reduce prostate size and serum PSA levels by 50%, though these changes may take at least 3 to 6 months to observe. The most common side effect of this class of medications is sexual dysfunction.[16] A combination of an alpha-adrenergic antagonist and finasteride appears to improve long-term outcomes of BPH.
Anticholinergic medications such as oxybutynin, solifenacin, and tolterodine or beta-3 adrenergic agonists such as mirabegron or vibegron can be used if overactive bladder symptoms (frequency, urgency) predominate. Anticholinergic medications are associated with side effects, such as dry mouth, constipation, and cognitive impairment, and so should be used with caution.[17]
Phosphodiesterase-5 inhibitors such as tadalafil and vardenafil may be considered for treatment in patients who have concomitant erectile dysfunction.[18]
Plant extracts from saw palmetto (Serenoa repens), Pygeum africanum, and Secale cereale, along with concentrated beta-sitosterol (a plant sterol), may play treatment roles but need further investigation.
Surgical options for severe refractory symptoms include transurethral resection of the prostate, transurethral incision of the prostate, open prostatectomy, laser prostatectomy (or photovaporization), microwave therapy, and transurethral needle ablation, among others. There are varying levels of evidence to support each of the above procedures.
Research studies have examined the relationship between dietary factors and the risk of BPH. The following factors are associated with reduced risk in epidemiologic studies:
Limiting or avoiding animal products and vegetable oils. Several studies have implicated high total meat and animal product intake in BPH, particularly beef and dairy products.[19][20] The Health Professionals Follow-Up Study found that higher intakes of total protein, animal protein, and polyunsaturated fatty acids, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and vegetable oils, were all associated with BPH.[21][22]
Including soy products. Asian men have a lower risk for prostate disease compared with their Western counterparts, which may be partly attributable to a higher intake of isoflavones and related compounds in their plant-rich diets.[23][24] Isoflavones in soy foods may inhibit 5-alpha reductase and aromatase, which, in turn, reduces the age-related increase in estrogen’s effect on prostate stromal cell proliferation.[23] Soy may also benefit prostate disease by lowering overall inflammation.[25]
Reducing energy intake. Some studies have shown an association between higher caloric intake and a greater risk for BPH. The Health Professionals Follow-Up Study reported a 50% increased risk for BPH in men in the highest decile of calorie intake compared with those in the lowest decile, as well as a 70% higher risk for moderate to severe lower urinary tract symptoms.[21]
Increasing fruit and vegetable intake. The Health Professionals Follow-Up Study found that consumption of fruits and vegetables overall, particularly those rich in beta-carotene, lycopene, lutein, zeaxanthin, and vitamin C, was inversely related to BPH incidence.[26] Examples of these foods are carrots, tomatoes, spinach, sweet potatoes, broccoli, collard greens, corn, oranges, melon, and kiwi. Citrus juice intake is associated with reduced BPH progression.[10] Limited evidence suggests that allium vegetable consumption (e.g., onions, garlic) is also inversely related to BPH incidence.[27]
Limiting coffee. Greater coffee or total caffeine intake is associated with increased odds of BPH progression.[10]
Vitamin D. Vitamin D deficiency is associated with prostate enlargement. Data suggest that vitamin D has an inhibitory effect on cyclooxygenase-2 expression and the production of prostaglandin E2 in BPH stromal cells, contributing to the decrease of prostate size in men with BPH.[28][29] There are currently no recommendations for supplementing vitamin D for the purpose of preventing or treating BPH.
See Basic Diet Orders chapter.
Low-fat diet.
Exercise prescription.
Risk of developing BPH can be influenced in part by lifestyle choices and is not necessarily a symptom of aging. Patients should consider following a reduced-fat diet that is free from animal products and includes regular consumption of soy foods. Effective medications are available with minimal side effects. Severe obstructive symptoms (e.g., urinary retention and bladder stones) should be treated with surgery to avoid permanent bladder failure or kidney damage.